DNA prime followed by protein boost enhances the protective efficacy against Schistosoma japonicum infection in mice.
- Author:
Bingchun LIU
1
;
Xinjie CUI
;
Xinsong LUO
;
Xiao WANG
Author Information
1. College of Life Sciences, Inner Mongolia University, Hohhot 010021, Inner Mongolia, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Antigens, Helminth;
immunology;
Female;
Glutathione Transferase;
administration & dosage;
immunology;
Helminth Proteins;
immunology;
Immunization, Secondary;
methods;
Mice;
Mice, Inbred C57BL;
Recombinant Fusion Proteins;
administration & dosage;
immunology;
Schistosoma japonicum;
Schistosomiasis japonica;
prevention & control;
Vaccination;
methods;
Vaccines, DNA;
administration & dosage;
immunology
- From:
Chinese Journal of Biotechnology
2013;29(6):814-822
- CountryChina
- Language:Chinese
-
Abstract:
Schistosomiasis japonica is an endemic, zoonotic disease of major public health importance in China. Vaccination is needed as a complementary approach to the ongoing control programs. In the present study, we determined if the efficacies of DNA vaccine encoding the SjGST and Sj32 asparaginyl endopeptidase protein could be enhanced by boosting with SjGST-32 protein vaccines. Mice were inoculated with a VR1012-SjGST-32 DNA vaccine followed by boosting with rSjGST-32 at 0, 14 and 28 d. Two weeks after the final boost, mice were challenged percutaneously with cercariae. On day 45 following the challenge, all mice were sacrificed and the numbers of recovered worms and hepatic eggs were counted. Moreover, we analyzed the immune response among various vaccination groups. The results showed that DNA vaccine efficacy was enhanced when mice were boosted with protein vaccine. Adult worm and liver egg burdens were reduced 42.3% and 59.6%, respectively. We further found that DNA vaccine followed by boosting with protein significantly increased the IgG titer and T cell proliferation over those seen in mice vaccinated solely with DNA vaccines. Furthermore, the higher level of IFN-gamma expression in the splenetic CD4+ T cell showed that DNA prime-Protein boosting vaccine induced CD4+ Th1-type responses. Thus, DNA vaccine efficacy was significantly enhanced via boosting protein vaccine which might provide a basis for rational application of the Schistosoma vaccine.
